Status:
TERMINATED
Performance Assessment of the PMD-200 in Subjects at Neurointensive Care Unit
Lead Sponsor:
Medasense Biometrics Ltd
Conditions:
Anesthesia, General
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Performance Assessment of the PMD-200, a Novel Pain Monitor, in Subjects at Neurointensive Care Unit.
Detailed Description
The proposed study is design to further demonstrates the performance of the Nociception Level (NoL) Index in neurological impaired anesthetized patients under general anesthesia, by evaluating its res...
Eligibility Criteria
Inclusion
- Age \> 18 years old.
- The subject is under general anesthesia
- The subject have a blood pressure measurement (either arterial or cuff) during the study
- A signed Informed Consent Form (ICF) has been obtain
Exclusion
- \- The subject is constantly agitate or moving a lot
Key Trial Info
Start Date :
March 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03452163
Start Date
March 8 2018
End Date
November 30 2019
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Galil Medical Center
Nahariya, Israel